Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 70,000 PLRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 70,000 | n/a |
| Mar 30, 2026 | Hercules Capital, Inc. (HTGC) | Purchase | 7,317 | $105.0K |
| Feb 25, 2026 | Hercules Capital, Inc. (HTGC) | Purchase | 6,600 | $100.3K |
| Nov 4, 2025 | Hercules Capital, Inc. (HTGC) | Purchase | 6,000 | $106.6K |
| Jun 10, 2025 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 30,000 | n/a |
| May 9, 2025 | Hercules Capital, Inc. (HTGC) | Purchase | 5,999 | $104.9K |
| Aug 8, 2024 | Hercules Capital, Inc. (HTGC) | Purchase | 5,790 | $104.6K |
| Jun 26, 2024 | Hercules Capital, Inc. (HTGC) | Purchase | 702 | $14.1K |
| Jun 24, 2024 | Hercules Capital, Inc. (HTGC) | Grant/Award | 3,030 | $60.0K |
| Jun 18, 2024 | PLIANT THERAPEUTICS, INC. (PLRX) | Grant/Award | 26,764 | n/a |